Tomita K - Search Results

1

Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients.

Anraku M, Kitamura K, Shinohara A, Adachi M, Suenga A, Maruyama T, Miyanaka K, Miyoshi T, Shiraishi N, Nonoguchi H, Otagiri M, Tomita K. Anraku M, et al. Among authors: tomita k. Kidney Int. 2004 Aug;66(2):841-8. doi: 10.1111/j.1523-1755.2004.00813.x. Kidney Int. 2004. PMID: 15253741 Free article. Clinical Trial.

2

Increased endothelin-1 expression in the kidney in hypercalcemic rats.

Shiraishi N, Kitamura K, Kohda Y, Narikiyo T, Adachi M, Miyoshi T, Iwashita K, Nonoguchi H, Miller RT, Tomita K. Shiraishi N, et al. Among authors: tomita k. Kidney Int. 2003 Mar;63(3):845-52. doi: 10.1046/j.1523-1755.2003.00801.x. Kidney Int. 2003. PMID: 12631065 Free article.

3

Inhibition of prostasin expression by TGF-beta1 in renal epithelial cells.

Tuyen DG, Kitamura K, Adachi M, Miyoshi T, Wakida N, Nagano J, Nonoguchi H, Tomita K. Tuyen DG, et al. Among authors: tomita k. Kidney Int. 2005 Jan;67(1):193-200. doi: 10.1111/j.1523-1755.2005.00070.x. Kidney Int. 2005. PMID: 15610243 Free article.

4

Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients.

Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Tomita K, Otagiri M. Mera K, et al. Among authors: tomita k. Hypertens Res. 2005 Dec;28(12):973-80. doi: 10.1291/hypres.28.973. Hypertens Res. 2005. PMID: 16671336

5

Effect of telmisartan on ambulatory blood pressure monitoring, plasma brain natriuretic peptide, and oxidative status of serum albumin in hemodialysis patients.

Shimada H, Kitamura K, Anraku M, Miyoshi T, Adachi M, Tuyen DG, Wakamatsu S, Nonoguchi H, Tanaka M, Tomita K. Shimada H, et al. Among authors: tomita k. Hypertens Res. 2005 Dec;28(12):987-94. doi: 10.1291/hypres.28.987. Hypertens Res. 2005. PMID: 16671338 Clinical Trial.

6

Effect of olmesartan on oxidative stress in hemodialysis patients.

Kadowaki D, Anraku M, Tasaki Y, Kitamura K, Wakamatsu S, Tomita K, Gebicki JM, Maruyama T, Otagiri M. Kadowaki D, et al. Among authors: tomita k. Hypertens Res. 2007 May;30(5):395-402. doi: 10.1291/hypres.30.395. Hypertens Res. 2007. PMID: 17587751 Clinical Trial.

7

Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.

Anraku M, Kitamura K, Shintomo R, Takeuchi K, Ikeda H, Nagano J, Ko T, Mera K, Tomita K, Otagiri M. Anraku M, et al. Among authors: tomita k. Clin Biochem. 2008 Oct;41(14-15):1168-74. doi: 10.1016/j.clinbiochem.2008.07.007. Epub 2008 Jul 28. Clin Biochem. 2008. PMID: 18692036 Clinical Trial.

8

Quantitative analysis of cysteine-34 on the anitioxidative properties of human serum albumin in hemodialysis patients.

Anraku M, Takeuchi K, Watanabe H, Kadowaki D, Kitamura K, Tomita K, Kuniyasu A, Suenaga A, Maruyama T, Otagiri M. Anraku M, et al. Among authors: tomita k. J Pharm Sci. 2011 Sep;100(9):3968-76. doi: 10.1002/jps.22571. Epub 2011 Apr 7. J Pharm Sci. 2011. PMID: 21480235

9

[Effects of fluvastatin on plasma lipid abnormalities in hemodialysis patients with chronic renal failure].

Tanaka M, Itoh K, Matsushita K, Kitamura K, Nonoguchi H, Tomita K. Tanaka M, et al. Among authors: tomita k. Nihon Jinzo Gakkai Shi. 2002 May;44(4):402-8. Nihon Jinzo Gakkai Shi. 2002. PMID: 12073626 Japanese.

10

Inhibition of prostasin secretion by serine protease inhibitors in the kidney.

Iwashita K, Kitamura K, Narikiyo T, Adachi M, Shiraishi N, Miyoshi T, Nagano J, Tuyen DG, Nonoguchi H, Tomita K. Iwashita K, et al. Among authors: tomita k. J Am Soc Nephrol. 2003 Jan;14(1):11-6. doi: 10.1097/01.asn.0000043900.39397.48. J Am Soc Nephrol. 2003. PMID: 12506133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,378 results

Search Page